130 related articles for article (PubMed ID: 16137204)
21. Miniature tissue-equivalent proportional counters for BNCT and BNCEFNT dosimetry.
Burmeister J; Kota C; Maughan RL; Waker AJ
Med Phys; 2001 Sep; 28(9):1911-25. PubMed ID: 11585222
[TBL] [Abstract][Full Text] [Related]
22. Cure of cervical cancer using 252Cf neutron brachytherapy.
Maruyama Y; van Nagell JR; Yoneda J; Donaldson ES; Gallion HH; Higgins R; Kryscio RJ
Strahlenther Onkol; 1990 May; 166(5):317-21. PubMed ID: 2190346
[TBL] [Abstract][Full Text] [Related]
23. Clinical evaluation of 252Cf neutron intracavitary therapy for primary endometrial adenocarcinoma.
Maruyama Y; Van Nagell JR; Yoneda J; DePriest P; Kryscio RJ
Cancer; 1993 Jun; 71(12):3932-7. PubMed ID: 8508359
[TBL] [Abstract][Full Text] [Related]
24. Paired Mg and Mg(B) ionization chambers for the measurement of boron neutron capture dose in neutron beams.
Burmeister J; Kota C; Yudelev M; Maughan RL
Med Phys; 1999 Nov; 26(11):2482-7. PubMed ID: 10587237
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of brachytherapy with californium-252 neutrons versus cesium-137 photons for eradication of bulky localized cervical cancer: single-institution study.
Maruyama Y; van Nagell JR; Yoneda J; Donaldson E; Gallion H; Higgins R; Powell D; Turner C; Kryscio R
J Natl Cancer Inst; 1988 Jun; 80(7):501-6. PubMed ID: 3367388
[TBL] [Abstract][Full Text] [Related]
26. Dosimetry for 252Cf neutron emitting brachytherapy sources: protocol, measurements, and calculations.
Rivard MJ
Med Phys; 1999 Aug; 26(8):1503-14. PubMed ID: 10501050
[TBL] [Abstract][Full Text] [Related]
27. A phase I trial of neutron brachytherapy for the treatment of malignant gliomas.
Patchell RA; Yaes RJ; Beach L; Kryscio RJ; Davis DG; Tibbs PA; Young B
Br J Radiol; 1997 Nov; 70(839):1162-8. PubMed ID: 9536908
[TBL] [Abstract][Full Text] [Related]
28. Intracavitary moderator balloon combined with (252)Cf brachytherapy and boron neutron capture therapy, improving dosimetry in brain tumour and infiltrations.
Brandão SF; Campos TP
Br J Radiol; 2015 Jul; 88(1051):20140829. PubMed ID: 25927876
[TBL] [Abstract][Full Text] [Related]
29. Microdosimetric intercomparison of BNCT beams at BNL and MIT.
Burmeister J; Riley K; Coderre JA; Harling OK; Ma R; Wielopolski L; Kota C; Maughan RL
Med Phys; 2003 Aug; 30(8):2131-9. PubMed ID: 12945978
[TBL] [Abstract][Full Text] [Related]
30. Measurement of the dose components of fast and thermal neutrons and photons from a 0.1 mg 252Cf source in water for brachytherapy treatment planning.
Wanwilairat S; Schmidt R; Vilaithong T; Lorvidhaya V; Hoffmann W
Med Phys; 2000 Oct; 27(10):2357-62. PubMed ID: 11099203
[TBL] [Abstract][Full Text] [Related]
31. A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancer.
Maruyama Y; Bowen MG; Van Nagell JR; Gallion HH; DePriest P; Wierzbicki J
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):529-34. PubMed ID: 8005811
[TBL] [Abstract][Full Text] [Related]
32. Development of high-activity 252Cf sources for neutron brachytherapy.
Martin RC; Laxson RR; Miller JH; Wierzbicki JG; Rivard MJ; Marsh DL
Appl Radiat Isot; 1997; 48(10-12):1567-70. PubMed ID: 9463877
[TBL] [Abstract][Full Text] [Related]
33. [Interstitial neutron therapy using flexible 252Cf sources].
Vtiurin BM; Medvedev VS; Ivanov VN; Elisiutin GP; Petrovskaia GA
Med Radiol (Mosk); 1984 Jun; 29(6):7-16. PubMed ID: 6738328
[TBL] [Abstract][Full Text] [Related]
34. Comparison of biological weighting functions to estimate the microdosimetric RBE in BNCT.
Selva A; Bianchi A; Bellan L; Fagotti E; Pisent A; Conte V
Radiat Prot Dosimetry; 2023 Oct; 199(15-16):1963-1967. PubMed ID: 37819342
[TBL] [Abstract][Full Text] [Related]
35. [Contact neutron therapy of tumors with 252Cf irradiation].
Vtiurin BM
Med Radiol (Mosk); 1987 Sep; 32(9):62-7. PubMed ID: 3657457
[TBL] [Abstract][Full Text] [Related]
36. Microdosimetric spectra of the THOR neutron beam for boron neutron capture therapy.
Hsu FY; Tung CJ; Watt DE
Radiat Prot Dosimetry; 2003; 104(2):121-6. PubMed ID: 12918789
[TBL] [Abstract][Full Text] [Related]
37. Neutron and gamma dose distribution for tandem, tandem and ovoid and plaque for intracavitary 252Cf therapy of cervix carcinoma.
Maruyama Y; Tai DL; Beach JL
Radiat Med; 1983; 1(3):230-6. PubMed ID: 6390538
[TBL] [Abstract][Full Text] [Related]
38. Compound dual radiation action theory for 252Cf brachytherapy.
Wang CK; Zhang X
Radiat Prot Dosimetry; 2004; 110(1-4):801-6. PubMed ID: 15353749
[TBL] [Abstract][Full Text] [Related]
39. Neutron interstitial brachytherapy for malignant gliomas: a pilot study.
Patchell RA; Maruyama Y; Tibbs PA; Beach JL; Kryscio RJ; Young AB
J Neurosurg; 1988 Jan; 68(1):67-72. PubMed ID: 2826722
[TBL] [Abstract][Full Text] [Related]
40. Production, distribution and applications of californium-252 neutron sources.
Martin RC; Knauer JB; Balo PA
Appl Radiat Isot; 2000; 53(4-5):785-92. PubMed ID: 11003521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
